De Jin

1.3k total citations
52 papers, 835 citations indexed

About

De Jin is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, De Jin has authored 52 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Pharmacology and 12 papers in Complementary and alternative medicine. Recurrent topics in De Jin's work include Pharmacological Effects of Natural Compounds (13 papers), Ginseng Biological Effects and Applications (8 papers) and Traditional Chinese Medicine Analysis (7 papers). De Jin is often cited by papers focused on Pharmacological Effects of Natural Compounds (13 papers), Ginseng Biological Effects and Applications (8 papers) and Traditional Chinese Medicine Analysis (7 papers). De Jin collaborates with scholars based in China, Malaysia and United States. De Jin's co-authors include Fengmei Lian, Xiaolin Tong, Liyun Duan, Yuting Sun, Xuedong An, Xiaomin Kang, Yingying Duan, Yuqing Zhang, Rongrong Zhou and Yuehong Zhang and has published in prestigious journals such as Journal of Ethnopharmacology, Medicine and Frontiers in Pharmacology.

In The Last Decade

De Jin

51 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
De Jin China 15 347 198 131 113 100 52 835
Mandeep Kumar Arora India 14 307 0.9× 75 0.4× 60 0.5× 173 1.5× 147 1.5× 40 894
Qingquan Liu China 16 336 1.0× 91 0.5× 71 0.5× 50 0.4× 168 1.7× 46 901
Jiangyi Yu China 13 199 0.6× 79 0.4× 48 0.4× 135 1.2× 97 1.0× 49 623
Zezheng Gao China 15 392 1.1× 97 0.5× 101 0.8× 114 1.0× 20 0.2× 30 694
Mohammad M. Al-Harbi Saudi Arabia 17 192 0.6× 335 1.7× 155 1.2× 52 0.5× 45 0.5× 26 941
Zhilei Wang China 19 654 1.9× 77 0.4× 259 2.0× 54 0.5× 171 1.7× 43 1.1k
Minzhou Zhang China 19 313 0.9× 270 1.4× 101 0.8× 66 0.6× 31 0.3× 73 1.1k
Xiangchang Zeng China 15 366 1.1× 55 0.3× 146 1.1× 36 0.3× 72 0.7× 23 707
Yi‐Gang Wan China 18 472 1.4× 186 0.9× 86 0.7× 58 0.5× 332 3.3× 65 999
Nermin Abdel Hamid Sadik Egypt 21 421 1.2× 63 0.3× 63 0.5× 65 0.6× 39 0.4× 53 1.2k

Countries citing papers authored by De Jin

Since Specialization
Citations

This map shows the geographic impact of De Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De Jin more than expected).

Fields of papers citing papers by De Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De Jin. The network helps show where De Jin may publish in the future.

Co-authorship network of co-authors of De Jin

This figure shows the co-authorship network connecting the top 25 collaborators of De Jin. A scholar is included among the top collaborators of De Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De Jin. De Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Jin, De, et al.. (2024). Identification and validation of diagnostic markers related to immunogenic cell death and infiltration of immune cells in diabetic nephropathy. International Immunopharmacology. 143(Pt 1). 113236–113236. 2 indexed citations
4.
Sun, Yuting, De Jin, Ziwei Zhang, et al.. (2023). N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1866(4). 194967–194967. 13 indexed citations
5.
Sun, Yuting, De Jin, Ziwei Zhang, et al.. (2023). Effects of antioxidants on diabetic kidney diseases: mechanistic interpretations and clinical assessment. Chinese Medicine. 18(1). 3–3. 11 indexed citations
6.
Zhou, Rongrong, De Jin, Yuqing Zhang, et al.. (2022). Investigating the Mechanisms of Pollen Typhae in the Treatment of Diabetic Retinopathy Based on Network Pharmacology and Molecular Docking. Evidence-based Complementary and Alternative Medicine. 2022. 1–14. 6 indexed citations
7.
Zhang, Yuqing, et al.. (2022). Mechanism of Cornus Officinalis in Treating Diabetic Kidney Disease Based on Network Pharmacology. Evidence-based Complementary and Alternative Medicine. 2022. 1–14. 5 indexed citations
8.
Wu, Haoran, Xinyi Fang, De Jin, et al.. (2022). Efficacy and Mechanism of the Jiangtang Tiaozhi Recipe in the Management of Type 2 Diabetes and Dyslipidaemia: A Clinical Trial Protocol. Frontiers in Pharmacology. 13. 827697–827697.
9.
Zhang, Yuehong, De Jin, Xuedong An, et al.. (2022). The Long-Term Effects of Non-Pharmacological Interventions on Diabetes and Chronic Complication Outcomes in Patients With Hyperglycemia: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 13. 838224–838224. 3 indexed citations
10.
Kang, Xiaomin, De Jin, Yuqing Zhang, et al.. (2022). Efficacy and mechanisms of traditional Chinese medicine for COVID-19: a systematic review. Chinese Medicine. 17(1). 30–30. 42 indexed citations
11.
Duan, Liyun, De Jin, Xuedong An, et al.. (2021). The Potential Effect of Rhizoma coptidis on Polycystic Ovary Syndrome Based on Network Pharmacology and Molecular Docking. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 10 indexed citations
13.
Jin, De, Xuedong An, Yuqing Zhang, et al.. (2021). Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking. Frontiers in Pharmacology. 12. 602218–602218. 9 indexed citations
14.
Zhang, Yuqing, De Jin, Xiaomin Kang, et al.. (2021). Signaling Pathways Involved in Diabetic Renal Fibrosis. Frontiers in Cell and Developmental Biology. 9. 696542–696542. 147 indexed citations
15.
An, Xuedong, Liyun Duan, De Jin, et al.. (2021). The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19. Biomedicine & Pharmacotherapy. 137. 111267–111267. 76 indexed citations
16.
Piao, Chunli, Qi Zhang, De Jin, et al.. (2020). A Study on the Mechanism of Milkvetch Root in the Treatment of Diabetic Nephropathy Based on Network Pharmacology. Evidence-based Complementary and Alternative Medicine. 2020(1). 6754761–6754761. 10 indexed citations
17.
Wu, Haoran, Jiaxing Tian, Jiangquan Liao, et al.. (2020). Efficacy and safety assessment of traditional Chinese medicine for metabolic syndrome. BMJ Open Diabetes Research & Care. 8(1). e001181–e001181. 11 indexed citations
18.
19.
Pang, Bing, Fengmei Lian, Xiyan Zhao, et al.. (2017). Prevention of type 2 diabetes with the traditional Chinese patent medicine: A systematic review and meta-analysis. Diabetes Research and Clinical Practice. 131. 242–259. 29 indexed citations
20.
Jin, De. (2007). Observation Research on Cloud Microphysics and Precipitation Affection of Stratiform Cloud Seeding by Liquid Carbon Dioxide. Chinese Journal of Atmospheric Sciences. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026